Whitehawk Therapeutics Inc

WHWK · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$64-$66-$61-$110
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$11$12$10$2
Change in WC$4-$3-$5$4
Other Non-Cash-$11-$3$6$82
Operating Cash Flow-$60-$60-$50-$22
Investing Activities
PP&E Inv.-$2-$4-$0-$0
Net Acquisitions$0$0$0$25
Inv. Purchases-$36-$64-$145$0
Inv. Sales/Matur.$63$152$13$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$25$83-$133$25
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$73$155
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0-$4
Other Fin. Act.$0$0$0-$9
Financing Cash Flow$0$0$73$142
Forex Effect$0$0$0$0
Net Chg. in Cash-$34$24-$110$145
Supplemental Information
Beg. Cash$63$39$149$4
End Cash$29$63$39$149
Free Cash Flow-$61-$64-$50-$22
Whitehawk Therapeutics Inc (WHWK) Financial Statements & Key Stats | AlphaPilot